Literature DB >> 10896291

Oxidative abnormalities in Menkes disease.

C Rizzo1, E Bertini, F Piemonte, V Leuzzi, G Sabetta, G Federici, A Luchetti, C Dionisi-Vici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10896291     DOI： 10.1023/a:1005675012708

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.

Authors:  I A Trounce; Y L Kim; A S Jun; D C Wallace
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

Review 2.  Menkes disease.

Authors:  S G Kaler
Journal:  Adv Pediatr       Date:  1994

3.  Clinical and biochemical consequences of copper-histidine therapy in Menkes disease.

Authors:  J Kreuder; A Otten; H Fuder; Z Tümer; T Tønnesen; N Horn; D Dralle
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

4.  Menkes X-linked disease: prenatal diagnosis of hemizygous males and heterozygous females.

Authors:  N Horn
Journal:  Prenat Diagn       Date:  1981-04       Impact factor: 3.050
  4 in total
  2 in total

1.  Hypertrophic cardiomyopathy, cataract, developmental delay, lactic acidosis: a novel subtype of 3-methylglutaconic aciduria.

Authors:  Gabriella Di Rosa; Federica Deodato; Ference J Loupatty; Cristiano Rizzo; Rosalba Carrozzo; Filippo M Santorelli; Sara Boenzi; Adele D'Amico; Giulia Tozzi; Enrico Bertini; Andrea Maiorana; Ronald J A Wanders; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2006-05-30       Impact factor: 4.982

2.  Augmented cerebellar lactate in copper deficient rat pups originates from both blood and cerebellum.

Authors:  Anna A Gybina; Joseph R Prohaska
Journal:  Metab Brain Dis       Date:  2009-03-25       Impact factor: 3.584
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.